G1 Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 4.96, indicating more challenging environment then in the first quarter 2024, but still, it is a far cry from any concerns. G1 Therapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2024 quarter, has increased to 74 days, from 51 days, in the Mar 31 2024 quarter.

If we take a look into Healthcare sector 294 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2024 from 1435 to 2155.

What is Receivable Turnover Ratio?
What is G1 Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GTHX Receivables Turnover Ratio	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Receivable Change	1.05 %	-27.28 %	14.36 %	-11.94 %	22.1 %
Y / Y Revenue Change	-60.97 %	11.82 %	45.1 %	-47.83 %	300.95 %
Receivable Turnover Ratio (TTM)	4.96	7.19	6.45	6.29	7.02
GTHX's Total Ranking	# 2155	# 1435	# 1459	# 2067	# 2007
Accounts Receivable average collection period days	74	51	57	58	52
Seq. Receivable Change	14.2 %	-8.14 %	36.93 %	-29.66 %	-17.81 %
Seq. Revenue Change	14.3 %	-2.67 %	20.92 %	-70.99 %	227.45 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 80
Healthcare Sector	# 295
Overall Market	# 2155

Receivable Turnover Ratio Statistics
High	Average	Low
0.67	0.33	0.1
(Mar 31 2024)		(Mar 31 2022)

GTHX Company Profile • Back to GTHX Efficiency Comparisons • Compare GTHX Receivables Turnover Ratio to its Competitors

Financial Statements
G1 Therapeutics Inc 's Accounts Receivable	$ 13 Millions	Visit GTHX's Balance sheet
G1 Therapeutics Inc 's Sales TTM	$ 58 Millions	Visit GTHX's Income Statement
Sources of GTHX's Revenues		Visit GTHX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GTHX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GTHX's Growth Rates	GTHX's Roa	GTHX's Inventory Turnover Ratio	GTHX's Dividend Comparisons
GTHX's Profitability Ratios	GTHX's Roi	GTHX's Asset Turnover Ratio	GTHX's Dividend Growth
GTHX's Valuation Ratios	GTHX's Roe	GTHX's Financial Strength Ratios	GTHX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2024	Receivable at quarter ending Jun 30 2024
Nrc Health	11.98	$ 146.280 Millions	$ 12.212 Millions
Corcept Therapeutics Inc	11.92	$ 569.610 Millions	$ 47.776 Millions
Petvivo Holdings Inc	11.71	$ 0.975 Millions	$ 0.083 Millions
Exact Sciences Corporation	11.60	$ 2,632.090 Millions	$ 226.869 Millions
Integrated Biopharma Inc	11.54	$ 49.884 Millions	$ 4.323 Millions
Rosecliff Acquisition Corp I	11.40	$ 22.531 Millions	$ 1.977 Millions
Ensysce Biosciences Inc	11.36	$ 1.493 Millions	$ 0.131 Millions
Sangamo Therapeutics Inc	11.29	$ 12.277 Millions	$ 1.087 Millions
Valion Bio Inc	11.27	$ 1.113 Millions	$ 0.099 Millions
Zomedica Corp	11.03	$ 25.267 Millions	$ 2.292 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	10.79	$ 3.106 Millions	$ 0.288 Millions
Lftd Partners Inc	10.76	$ 46.780 Millions	$ 4.347 Millions
Sunshine Biopharma Inc	10.71	$ 30.482 Millions	$ 2.847 Millions
Lipella Pharmaceuticals Inc	10.70	$ 0.507 Millions	$ 0.047 Millions
National Healthcare Corp	10.60	$ 1,187.233 Millions	$ 111.976 Millions
Sunlink Health Systems Inc	10.57	$ 32.442 Millions	$ 3.069 Millions
Tandem Diabetes Care Inc	10.54	$ 795.884 Millions	$ 75.498 Millions
Reflect Scientific Inc	10.29	$ 1.734 Millions	$ 0.168 Millions
Procyon Corporation	10.28	$ 4.984 Millions	$ 0.485 Millions
Strata Critical Medical Inc	10.22	$ 238.379 Millions	$ 23.329 Millions
Option Care Health Inc	10.18	$ 4,589.168 Millions	$ 450.641 Millions
Tonix Pharmaceuticals Holding Corp	10.17	$ 12.458 Millions	$ 1.225 Millions
Immucell Corporation	10.11	$ 21.889 Millions	$ 2.166 Millions
Addus Homecare Corp	9.88	$ 1,112.632 Millions	$ 112.633 Millions
Escalon Medical Corp	9.68	$ 11.982 Millions	$ 1.238 Millions
Clearpoint Neuro Inc	9.66	$ 28.069 Millions	$ 2.905 Millions
Quidelortho Corp	9.64	$ 2,834.600 Millions	$ 293.925 Millions
Dianthus Therapeutics Inc	9.59	$ 5.563 Millions	$ 0.580 Millions
Bluebird Bio Inc	9.55	$ 54.900 Millions	$ 5.750 Millions
Onemednet Corporation	9.51	$ 1.142 Millions	$ 0.120 Millions

Date modified: 2026-08-30T19:08:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.